Loading clinical trials...
Loading clinical trials...
Prospective Study:Clinical Trial on the Tacrolimus Dosage Range in Chinese Renal Transplant Recipients With Different Genetic Phenotypes of Drug Metabolizing Enzymes(CYP3A5)
Conditions
Interventions
Tacrolimus
Locations
5
China
Chaoyang Hospital, affiliated Hospital of Capital Medical University
Beijing, Beijing Municipality, China
General Hospital of Air Force of Chinese PLA
Beijing, Beijing Municipality, China
The Second Artillery Gernal Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Changzheng Hospital, the Second Affiliated Hospital of the Second Military Medical University
Shanghai, Shanghai Municipality, China
Start Date
July 1, 2009
Primary Completion Date
December 1, 2010
Completion Date
June 1, 2011
Last Updated
December 22, 2011
NCT07294183
NCT05086003
NCT03478215
NCT03504241
NCT04774575
NCT05208788
Lead Sponsor
The Second Artillery General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions